MIF and markers of the inflammatory response following cardiac surgery under extracorporeal circulation

Applied Cardiopulmonary Pathophysiology

Volumn 14, Issue 2, 2010, Pages 115-123

  Bernhard, Michael ^a   Schultz, Konrad Martin ^a   Hofer, Stefan ^a   Hainer, Christian ^a   Gegouskov, Vassil ^a   Martin, Eike ^a   Karck, Matthias ^a   Motsch, Johann ^a   Weigand, Markus A ^a,c   Luntz, Steffen P ^b   Lichtenstern, Christoph ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Coordination Centre for Clinical Trials ^*  (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cardiac surgery; Macrophage migration inhibitor factor; Sicam; Systemic inflammatory response

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PATIENT; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

EID: 77954589732     PISSN: 09205268     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bacher M, Metz CN, Calandra T et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93 (15): 7849-7854
2. Beishuizen A, Thijs LG, Haanen C et al. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001; 86 (6): 2811-2816
3. Boyle EM, Pohlman TH, Johnson MC et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg 1997; 63 (1): 277-284
4. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55 (2): 552-559
5. Cain BS, Meldrum DR, Dinarello CA et al. Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 1999; 27 (7): 1309-1318
6. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3 (10): 791-800
7. Calandra T, Bucala R. Macrophage migration inhibitory factor (MIF): a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 1997; 17 (1): 77-88
8. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61 (6): 1714-1720
9. DeMendonca-Filho HTF, Pereira KC, Fontes M, et al. Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study. Crit Care 10 (2): R46
10. Donnelly SC, Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today 3 (11): 502-507
11. Finn A, Naik S, Klein N, et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 105 (2): 234-241
12. Fisman EZ, Benderly M, Esper RJ et al. Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction. Am J Cardiol 2006; 98 (1): 14-18
13. Gando S, Nishihira J, Kobayashi S et al. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Med 2001; 27 (7): 1187-1193
14. Grunenfelder J, Zund G, Schoeberlein A et al. Expression of adhesion molecules and cytokines after coronary artery bypass grafting during normothermic and hypothermic cardiac arrest. Eur J Cardiothorac Surg 2000; 17 (6): 723-728
15. Hirai S. Systemic inflammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 2003; 9 (6): 365-370
16. Holzheimer RG, Molloy RG, Gorlach H et al. IL-6 and TNF alpha release in association with neutrophil activation after cardiopul-monary bypass surgery. Infection 1994; 22 (1): 37-42
17. Koopman G, Parmentier HK, Schuurman HJ et al. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function-associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med 1991; 173 (6): 1297-1304
18. Lo SK, Golenbock DT, Sass PM et al. Engagement of the Lewis X antigen (CD15) results in monocyte activation. Blood 1997; 89 (1): 307-314
19. Menasche P. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol 1995; 10 (6): 597-604
20. Mojcik CF, Levy JH. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001; 71 (2): 745-754
21. Prondzinsky R, Knupfer A, Loppnow H et al. Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005; 129 (4): 760-766
22. Risnes I, Ueland T, Lundblad R et al. Changes in the cytokine network and complement parameters during open heart surgery. Interact Cardiovasc Thorac Surg 2003; 2 (1): 19-24
23. Royston D. The inflammatory response and extracorporeal circulation. J Cardiothorac Vasc Anesth 1997; 11 (3): 341-354
24. Ruel M, Bianchi C, Khan TA et al. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg 2003; 126 (5): 1521-1530
25. Sablotzki A, Borgermann J, Baulig W et al. Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Thorac Cardiovasc Surg 2001; 49 (5): 273-278
26. Schmartz D, Tabardel Y, Preiser JC et al. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients? J Thorac Cardiovasc Surg 2003; 125 (1): 184-190
27. Sehgal PB, Wang L, Rayanade R, et al. Interleukin-6-type cytokines. Ann N Y Acad Sci 1995; 21, 762: 1-14
28. Strohmeyer JC, Blume C, Meisel C et al. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry B Clin Cytom 2003; 53 (1): 54-62
29. Vallely MP, Bannon PG, Hughes CF et al. Endothelial expression of intercellular adhesion molecule 1 and vascular cell adhesion molecule 1 is suppressed by postbypass plasma containing increased soluble intercellular adhesion molecule 1 and vascular cell adhesion molecule 1. J Thorac Cardiovasc Surg 2002, 124 (4): 758-767
30. Volk T, Schmutzler M, Engelhardt L et al. Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass. Crit Care Med 2001; 29 (11): 2137-2142
31. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997; 112 (3): 676-692
32. Wei M, Kuukasjarvi P, Laurikka J, et al. Cytokine responses and myocardial injury in coronary artery bypass grafting. Scand J Clin Lab Invest 61 (2): 161-166
33. Weigand MA, Schmidt H, Pourmahmoud M et al. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 1999; 27 (12): 2656-2661